+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Symbicort - Product Thumbnail Image

Symbicort

  • Report
  • July 2018
  • 30 Pages
  • Global
From
Nucala - Product Thumbnail Image

Nucala

  • Report
  • July 2018
  • 27 Pages
  • Global
From
Asthma Forecast and Market Analysis to 2024 - Product Thumbnail Image

Asthma Forecast and Market Analysis to 2024

  • Report
  • February 2018
  • 680 Pages
  • Global
From
Drug Analysis: Cinqair - Product Thumbnail Image

Drug Analysis: Cinqair

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
Drug Analysis: Trelegy Ellipta - Product Thumbnail Image

Drug Analysis: Trelegy Ellipta

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
Drug Overview: Cinqair - Product Thumbnail Image

Drug Overview: Cinqair

  • Report
  • February 2018
  • 16 Pages
  • Global
From
Drug Overview: Fasenra - Product Thumbnail Image

Drug Overview: Fasenra

  • Report
  • February 2018
  • 23 Pages
  • Global
From
Xopenex - API Insight, 2022 - Product Thumbnail Image

Xopenex - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Singulair Paediatric - API Insight, 2022 - Product Thumbnail Image

Singulair Paediatric - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Mucodyne - API Insight, 2022 - Product Thumbnail Image

Mucodyne - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Fumarate De Formoterol - API Insight, 2022 - Product Thumbnail Image

Fumarate De Formoterol - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Rocephin - API Insight, 2022 - Product Thumbnail Image

Rocephin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Geninax - API Insight, 2022 - Product Thumbnail Image

Geninax - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zenhale - API Insight, 2022 - Product Thumbnail Image

Zenhale - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Qvarspray - API Insight, 2022 - Product Thumbnail Image

Qvarspray - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Pulmicort Turbuhaler - API Insight, 2022 - Product Thumbnail Image

Pulmicort Turbuhaler - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Tobi - API Insight, 2022 - Product Thumbnail Image

Tobi - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Tiotropium - API Insight, 2022 - Product Thumbnail Image

Tiotropium - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Invanz - API Insight, 2022 - Product Thumbnail Image

Invanz - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Esbriet - API Insight, 2022 - Product Thumbnail Image

Esbriet - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more